0001127602-18-025492.txt : 20180815
0001127602-18-025492.hdr.sgml : 20180815
20180815173744
ACCESSION NUMBER: 0001127602-18-025492
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180814
FILED AS OF DATE: 20180815
DATE AS OF CHANGE: 20180815
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Spears Michael P
CENTRAL INDEX KEY: 0001667779
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33462
FILM NUMBER: 181021854
MAIL ADDRESS:
STREET 1: C/O INSULET CORPORATION
STREET 2: 600 TECHNOLOGY PARK DRIVE, SUITE 200
CITY: BILLERICA
STATE: MA
ZIP: 01821
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INSULET CORP
CENTRAL INDEX KEY: 0001145197
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 043523891
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 600 TECHNOLOGY PARK
STREET 2: SUITE 200
CITY: BILLERICA
STATE: MA
ZIP: 01821
BUSINESS PHONE: 978-600-7000
MAIL ADDRESS:
STREET 1: 600 TECHNOLOGY PARK
STREET 2: SUITE 200
CITY: BILLERICA
STATE: MA
ZIP: 01821
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2018-08-14
0001145197
INSULET CORP
PODD
0001667779
Spears Michael P
C/O INSULET CORPORATION
600 TECHNOLOGY PARK DRIVE, SUITE 200
BILLERICA
MA
01821
1
SVP, QA and RA
Common Stock
2018-08-14
4
S
0
4400
85.972
D
27947
D
Common Stock
2018-08-14
4
S
0
643
86.837
D
27304
D
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018, as amended on May 17, 2018.
The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $85.45 to $86.41. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
Includes 4,328 restricted stock units granted on February 22, 2017, which vest as to one-half of the total units on February 22, 2019 and one-half of the total units on February 22, 2020; 3,418 restricted stock units granted on February 24, 2016, which vest on February 24, 2019; 5,982 performance share units granted on February 24, 2016, which vest on February 24, 2019; and 4,027 restricted stock units granted on February 14, 2018, which vest as to one-third of the total units on February 14, 2019, one-third of the total units on February 14, 2020 and one-third of the total units on February 14, 2021, subject to continued employment. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date.
The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $86.69 to $87.02. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
/s/ David Colleran, attorney-in-fact
2018-08-15